Patents Assigned to A/S
  • Patent number: 7314870
    Abstract: The present invention relates to novel compounds that are found to be cholinergic ligands at the nicotinic acetylcholine receptors and modulators of the monoamine receptors and transporters. Due to their pharmacological profile the compounds of the invention may be useful for the treatment of diseases or disorders as diverse as those related to the cholinergic system of the central nervous system (CNS), the peripheral nervous system (PNS), diseases or disorders related to smooth muscle contraction, endocrine diseases or disorders, diseases or disorders related to neuro-degeneration, diseases or disorders related to inflammation, pain, and withdrawal symptoms caused by the termination of abuse of chemical substances.
    Type: Grant
    Filed: July 2, 2002
    Date of Patent: January 1, 2008
    Assignee: Neurosearch A/S
    Inventors: Dan Peters, Gunnar M. Olsen, Elsebet Ostergaard Nielsen, Philip K. Ahring, Tino Dyhring Jorgensen
  • Patent number: 7315626
    Abstract: The invention relates to a hearing aid with optimized and controllable power consumption. The power consumption is controlled by varying the voltage level of the supply voltage and/or the frequency of the clock signal. Furthermore the invention relates to a method of optimizing the power consumption of a hearing aid, by calibrating its supply voltage and its clock frequency, and the relation between them, according to the production characteristics of the digital signal processor.
    Type: Grant
    Filed: September 20, 2002
    Date of Patent: January 1, 2008
    Assignee: Microsound A/S
    Inventor: Søren Louis Pedersen
  • Publication number: 20070298080
    Abstract: The invention proposes the use of at least one strain of Lactobacillus acidophilus to prepare a support administered to humans or animals with an analgesic purpose in the gastrointestinal system.
    Type: Application
    Filed: September 21, 2005
    Publication date: December 27, 2007
    Applicant: Danisco A/S
    Inventors: Pierre Desreumaux, Didier Carcano
  • Publication number: 20070299102
    Abstract: The present invention relates to substituted 3,3-diphenyl-1,3-dihydro-indol-2-one compounds, and the use of such compounds for the preparation of a medicament for the treatment of cancer in a mammal. It is postulated that treatment of cancers is achieved in which inhibition of protein synthesis and/or inhibition of activation of the mTOR pathway is an effective method for reducing cell growth. Examples of such cancers are breast cancer, renal cancer, multiple myeloma, leukemia, glia blastoma, rhabdomyosarcoma, prostate, soft tissue sarcoma, colorectal sarcoma, gastric carcinoma, head and neck squamous cell carcinoma, uterine, cervical, melanoma, lymphoma, and pancreatic cancer. A particular subclass of compounds are represented by the formula (II) wherein at least one of X1 and X2 is a heteroatom substituent, e.g. 6-chloro-3,3-bis-(4-hydroxy-phenyl)-7-methyl-1,3-dihydro-indol-2-one.
    Type: Application
    Filed: April 8, 2005
    Publication date: December 27, 2007
    Applicant: Topo Target A/S
    Inventors: Jakob Felding, Hans Pedersen, Christian Krog-Jensen, Morten Praestegaard, Steven Butcher, Viggo Linde, Thomas Coulter, Christian Montalbetti, Mohammed Uddin, Serge Reignier
  • Publication number: 20070296220
    Abstract: The invention relates to a wind turbine including a foundation and a tower positioned on the foundation where the tower includes more than one modules, where the modules each include a separate strengthening structure defining the outer edges of the module and wind turbine equipment, and where the more than one module are positioned substantially vertically on top of each other in an upright position within the tower. The modules are connected directly and/or indirectly through the strengthening structure, to the foundation (18). The invention further relates to a method for assembling a wind turbine at a wind turbine site and a method for handling more than one wind turbine modules.
    Type: Application
    Filed: November 23, 2004
    Publication date: December 27, 2007
    Applicant: VESTAS WIND SYSTEMS A/S
    Inventor: Jonas Kristensen
  • Patent number: 7311007
    Abstract: The invention provides a pressure sensor with a housing for a pressure sensing arrangement, e.g. a semi-conductor arrangement. The housing consists of a bottom part and an intermediate member with a through hole forming a sidewall of a cavity for the pressure sensing arrangement. A membrane is attached to the intermediate member to cover an opening of the cavity, and to allow pressure from outside to propagate into a pressure transmitting medium contained inside the housing and thus to the pressure sensing arrangement therein. The invention also provides a method of making a pressure sensor with a housing of the above-described kind.
    Type: Grant
    Filed: December 10, 2003
    Date of Patent: December 25, 2007
    Assignee: Danfoss A/S
    Inventor: Jes Vogler
  • Patent number: 7311698
    Abstract: A catheter assembly allowing for non-contaminated insertion of the catheter into the urinary canal. The catheter assembly includes a urinary catheter, a catheter package and a sealing member. The urinary catheter defines a conduit and has a proximal end adapted for insertion into the urinary canal and an opposite distal end. The catheter package has a hose with a cavity for accommodation of the catheter, and a catheter outlet adapted to dismantle the proximal end of the catheter from the catheter package. The sealing member is adapted to provide a substantially liquid-tight seal between the catheter package and the urinary catheter while the catheter is being dismantled.
    Type: Grant
    Filed: December 27, 2001
    Date of Patent: December 25, 2007
    Assignee: Coloplast A/S
    Inventors: Allan Tanghoj, Lars Bogelund Jensen
  • Patent number: 7311915
    Abstract: The present invention comprises novel and modified peptides capable of inducing an HIV-1 specific immune response without antagonizing the cytotoxic T-cell activity in order to achieve an effective prophylactic and therapeutic vaccine against HIV. The peptides are based on conserved regions of HIV gag p24 proteins. Antigens in free- or carrier-bound form comprising at least one of the said peptides, vaccine compositions containing at least one of the antigens, immunoassay kits and a method of detecting antibodies induced by HIV or HIV specific peptides using such antigens, are described.
    Type: Grant
    Filed: September 11, 2003
    Date of Patent: December 25, 2007
    Assignee: Bionor A/S
    Inventor: Birger Sorensen
  • Patent number: 7312055
    Abstract: The present invention relates to a hybrid enzyme comprising at least one carbohydrate-binding module amino acid sequence and at least the catalytic module of a glucoamylase amino acid sequence. The invention also relates to the use of the hybrid enzyme in starch processing and especially ethanol production.
    Type: Grant
    Filed: July 21, 2006
    Date of Patent: December 25, 2007
    Assignees: Novozymes A/S, Novozymes North America, Inc.
    Inventors: Torben V. Borchert, Steffen Danielsen, Eric J. Allain
  • Patent number: 7312062
    Abstract: The substrate specificity of a lipolytic enzyme can be modified by making alterations to the amino acid sequence in a defined region of the lipolytic enzyme, so as to increase the level of a desired activity or to decrease the level of an undesired activity. Thus, the inventors have developed lipolytic enzyme variants with a modified amino acid sequence with a substrate specificity which can be tailored for specific uses.
    Type: Grant
    Filed: November 22, 2004
    Date of Patent: December 25, 2007
    Assignee: Novozymes A/S
    Inventors: Kirsten Bojsen, Allan Svendsen, Claus Crone Fuglsang, Shamkant Anant Patkar, Kim Borch, Jesper Vind, Andreas Petri, Sanne O. Schrøder Glad, Gitte Budolfsen
  • Publication number: 20070292310
    Abstract: Micro fluidic system for analysing species within a fluid medium includes at least one first fluid reservoir (12) holding a carrier fluid, a second fluid reservoir(s) (13-15) holding reagent fluid(s) producing measurable chemical reactions when mixed with the species, detecting arrangement (54) able to detect the measurable chemical reactions, a membrane (61) permeable to the species, the membrane being in downstream fluid communication with the first fluid reservoir (12) and in upstream fluid communication with analysing mechanism (50), the first fluid reservoir(s) and the second fluid reservoir(s) being stored in storage container (10) and in downstream fluid communication with pressurizing mechanism through connecting mechanism (6), wherein the analysing mechanism comprise one substrate with micro-channels and covered in a fluid tight manner by a sheet, the micro-channels at said one substrate defining at least one meandering part(s) (51, 52) for mixing and/or reacting the reagent fluid(s) to the carrier f
    Type: Application
    Filed: May 13, 2005
    Publication date: December 20, 2007
    Applicant: Danfoss A/S
    Inventor: Peter Gravesen
  • Publication number: 20070290386
    Abstract: A production light comprising a housing (1) with a synchronous driving mechanism with at least two rollers (2,4) where a film/band (6) of gels (8) is wound and taut between the rollers (2,4) so the aperture (10) of the production light is covered by the film/band (6), characterized in that the film/band (6) comprises of a plurality of separate sections of gels (8) where the gels (8) are attached to the film/band (6) by fastening means in such a way that each section of gel (8) is easily mounted or remounted onto the film/band (6).
    Type: Application
    Filed: November 10, 2005
    Publication date: December 20, 2007
    Applicant: MARTIN PROFESSIONAL A/S
    Inventors: Thomas Andersen, Jan Hansen
  • Publication number: 20070292520
    Abstract: The present invention provides methods and compositions for treating diabetes by administering insulin or an insulin analog via a pulmonary route, wherein the insulin or insulin analog is in crystalline form with a diameter below 10 microns when recovered from a solution having a pH between 7.0 and 9.5. The insulin or insulin analog may be in the form of a dry. The present invention provides methods and compositions for treating diabetes by administering acylated insulin or an acylated insulin analog via a pulmonary route. The insulin or insulin analog may be in the form of a dry powder or a solution.
    Type: Application
    Filed: July 6, 2007
    Publication date: December 20, 2007
    Applicant: Novo Nordisk A/S
    Inventor: Svend Havelund
  • Publication number: 20070293742
    Abstract: This invention relates to an system for self treatment. The system consists of several portable modules where one of the modules is designated as a master module. The master module controls, supervises and monitors all the mutual information and data exchange between itself and the rest of the modules. The modules can e.g. consist of a BGM, a doser and a storage container. The modules may be able to generate and store data which is transmitted to the master module if it is within range. If the master module is not within range, the data is kept locally in the module until the master module is available. The master module can send the data to an external unit like a computer or database for further processing. A physician or an expert care-team can access the data in the database and give guidance to the patient on the basis of these processed data. This processing could also be done automatically by utilization of an expert system.
    Type: Application
    Filed: August 28, 2007
    Publication date: December 20, 2007
    Applicant: Novo Nordisk A/S
    Inventors: Jan Simonsen, Jens Poulsen, Kent Rokkjaer, Lars Christensen, Soren Aasmul, Steffen Lav
  • Publication number: 20070292841
    Abstract: The present invention relates to in vitro methods of screening human subjects for the presence of human papillomavirus (HPV) which exhibits loss of regulation of E6/E7 mRNA expression and loss of replication and/or expression of a stabilized pre-mRNA encoding full length E6 protein. In particular, the invention provides in vitro methods of screening for persistent cell abnormalities or persistent CIN III lesions, cancer in situ or high-grade squamous intraepithelial lesions (HSIL). The methods are useful in the context of cervical cancer screening.
    Type: Application
    Filed: February 28, 2005
    Publication date: December 20, 2007
    Applicant: Norchip A/S
    Inventor: Frank Karlsen
  • Publication number: 20070292938
    Abstract: The present invention relates to a method for extracting components from yeast cells with a purified phospholipase.
    Type: Application
    Filed: May 8, 2007
    Publication date: December 20, 2007
    Applicant: Novozymes A/S
    Inventors: Lisbeth Kalum, Per Nielsen, Steffen Ernst
  • Publication number: 20070292581
    Abstract: The inventors have found a novel fungal lipoxygenase from Manaporthe salvinii and determined its sequence. They have sequenced the gene and cloned it into E. coli and deposited the clone. Oligonucleotides probes based on the sequence information are useful for screening a eukaryotic library to obtain a lipoxygenase. The lipoxygenase is useful in baking and in a detergent.
    Type: Application
    Filed: August 1, 2007
    Publication date: December 20, 2007
    Applicant: Novozymes A/S
    Inventors: Akiko Sugio, Shinobu Takagi
  • Patent number: 7309508
    Abstract: A non-lauric, non-trans, non-temper (Non-LTT) fat composition comprising a fraction obtained from a randomised triglyceride mixture in which min. 90% by weight of the constituent fatty acids are: palmitic (C16:0), stearic (C18:0), arachidic (C20:0) behenic (C22:0), oleic (C18:1) and linoleic (C18:2) acid and the total content of arachidic and behenic acid is 3-40% by weight and the total content of palmitic and stearic acids is 25-60% by weight, said fraction having the following physical and chemical properties: (1) slip melting point measured according to AOCS Cc 3-25: below 36° C. and solid fat content (SFC) measured according to IUPAC 2.150 mod. (stabilised at 20° C. for 24 h): above 25% by weight at 20° C.; (2) total content of saturated fatty acids measured according to IUPAC 2.301 and 2.
    Type: Grant
    Filed: April 27, 2004
    Date of Patent: December 18, 2007
    Assignee: Aarhuskarlshamn Denmark A/S
    Inventors: Mogens Bach, Bjarne Juul
  • Patent number: PP18317
    Abstract: A new garden rose plant of the floribunda class which has abundant, pink flowers and attractive foliage. This new and distinct variety has shown to be uniform and stable in the resulting generations from asexual propagation.
    Type: Grant
    Filed: June 5, 2006
    Date of Patent: December 18, 2007
    Assignee: Poulsen Roser A/S
    Inventor: Mogens N. Olesen
  • Patent number: D558796
    Type: Grant
    Filed: May 24, 2005
    Date of Patent: January 1, 2008
    Assignee: Danfoss A/S
    Inventor: Kristoffer Riemann Hansen